| Bioactivity | HYNIC-iPSMA is a ligand for molecular imaging of tumors. Hynic-ipsma consists of two components: HYNIC (6-hydrazinonicotinamide) and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules. iPSMA is a specific inhibitor used to inhibit prostate-specific membrane antigen (PSMA). 68GA-labeled iPSMA has been used to detect prostate cancer by PET imaging. The further 99mTc-EDDA/HYNIC-iPSMA has excellent specificity and sensitivity[1]. |
| Name | HYNIC-iPSMA |
| CAS | 2192215-74-8 |
| Sequence | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu |
| Shortening | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu |
| Formula | C31H37N7O9 |
| Molar Mass | 651.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ferro-Flores G, et al. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Nucl Med Biol. 2017 May;48:36-44. |
HYNIC-iPSMA
CAS: 2192215-74-8 F: C31H37N7O9 W: 651.67
HYNIC-iPSMA is a ligand for molecular imaging of tumors. Hynic-ipsma consists of two components: HYNIC (6-hydrazinonicot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.